| RS863225017 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS863225018 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS863225019 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS863225020 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS863225021 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS863225022 |
HSPB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2F, Inborn genetic diseases |
| RS863225023 |
HSPB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2F, Charcot-Marie-Tooth disease |
| RS863225024 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial partial lipodystrophy, Dunnigan type |
| RS863225025 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS863225026 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS863225027 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type IA |
| RS863225028 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS863225029 |
PMP22
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type IA |
| RS863225030 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS863225031 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS863225032 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS863225033 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS863225034 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS863225035 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS863225036 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS863225037 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS863225038 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS863225041 |
BMPR1B
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 3, Acromesomelic dysplasia 3 |
| RS863225042 |
BMPR1B
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 3, Acromesomelic dysplasia 3 |
| RS863225043 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS863225044 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS863225045 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS863225047 |
LIFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS863225048 |
EIF2B1
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS863225049 |
EIF2B1
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS863225050 |
EIF2B1
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS863225051 |
EIF2B1
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS863225052 |
EIF2B1
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS863225053 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Interstitial lung disease 2, Pulmonary fibrosis and/or bone marrow failure |
| RS863225054 |
PTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS863225055 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS863225058 |
ACAD9
|
Health Risk |
Likely pathogenic |
— |
| RS863225059 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS863225060 |
PIK3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
PIK3CA related overgrowth syndrome, Cowden syndrome |
| RS863225061 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS863225062 |
HIBCH
|
Health Risk |
Likely pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS863225064 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS863225065 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS863225066 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS863225068 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Epileptic encephalopathy |
| RS863225070 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS863225072 |
SLC2A9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypouricemia, renal |
| RS863225073 |
CHAMP1
|
Health Risk |
Likely pathogenic |
— |
| RS863225074 |
CHAMP1
|
Health Risk |
Pathogenic |
CHAMP1-related syndrome, CHAMP1-related syndrome |
| RS863225075 |
CHAMP1
|
Health Risk |
Pathogenic |
CHAMP1-related syndrome, CHAMP1-related syndrome |
| RS863225076 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS863225077 |
CHAMP1
|
Health Risk |
Pathogenic |
CHAMP1-related syndrome, Intellectual disability |
| RS863225078 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS863225079 |
PPP2R5D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hogue-Janssens syndrome 1, Inborn genetic diseases |
| RS863225080 |
PPP2R5D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Hogue-Janssens syndrome 1 |
| RS863225081 |
PPP2R5D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hogue-Janssens syndrome 1, PPP2R5D-related disorder |
| RS863225082 |
MEA1;PPP2R5D
|
Health Risk |
Pathogenic |
Hogue-Janssens syndrome 1, Inborn genetic diseases |
| RS863225083 |
PEX6
|
Health Risk |
Pathogenic |
Heimler syndrome 2, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS863225084 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Heimler syndrome 1, Retinal dystrophy |
| RS863225085 |
PEX1
|
Health Risk |
Pathogenic |
Heimler syndrome 1, Heimler syndrome 1 |
| RS863225086 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS863225087 |
MPI
|
Health Risk |
Pathogenic/Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS863225088 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DPAGT1-congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS863225089 |
MOGS
|
Health Risk |
Likely pathogenic |
MOGS-congenital disorder of glycosylation, MOGS-congenital disorder of glycosylation |
| RS863225090 |
CACNA1F
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS863225091 |
RORC
|
Health Risk |
Pathogenic |
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency |
| RS863225092 |
RORC
|
Health Risk |
Pathogenic |
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency |
| RS863225093 |
DGAT1
|
Health Risk |
Likely pathogenic |
Congenital diarrhea 7 with exudative enteropathy, Congenital diarrhea 7 with exudative enteropathy |
| RS863225094 |
PPP2R1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS863225095 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS863225096 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS863225097 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS863225098 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Cardiomyopathy |
| RS863225099 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS863225100 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Cardiovascular phenotype |
| RS863225101 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS863225102 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS863225103 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS863225104 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Cardiovascular phenotype |
| RS863225105 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS863225106 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Cardiovascular phenotype |
| RS863225107 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS863225109 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS863225111 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS863225112 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS863225113 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Cardiomyopathy |
| RS863225114 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS863225117 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 10, Cardiomyopathy |
| RS863225119 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS863225120 |
TNNT2
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy 2 |
| RS863225121 |
VCL
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 15, Hypertrophic cardiomyopathy 15 |
| RS863225122 |
HARS1
|
Health Risk |
Pathogenic |
Autosomal dominant Charcot-Marie-Tooth disease type 2W, Autosomal dominant Charcot-Marie-Tooth disease type 2W |
| RS863225123 |
HARS1
|
Health Risk |
Pathogenic |
Autosomal dominant Charcot-Marie-Tooth disease type 2W, Autosomal dominant Charcot-Marie-Tooth disease type 2W |
| RS863225124 |
HARS1
|
Health Risk |
Pathogenic |
Autosomal dominant Charcot-Marie-Tooth disease type 2W, Autosomal dominant Charcot-Marie-Tooth disease type 2W |
| RS863225125 |
PDHB
|
Health Risk |
Pathogenic |
— |
| RS863225126 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS863225127 |
KNL1
|
Health Risk |
Pathogenic |
Microcephaly 4, primary |
| RS863225128 |
OCLN
|
Health Risk |
Likely pathogenic |
Pseudo-TORCH syndrome 1, Pseudo-TORCH syndrome 1 |
| RS863225129 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Interstitial lung disease 2, Dyskeratosis congenita |
| RS863225130 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease 2, Dyskeratosis congenita |